A new hope for vascular access, modifying a new technique: The Surfacer® Inside-Out Access Catheter System and sharp recanalization

Semin Dial. 2023 Nov-Dec;36(6):483-485. doi: 10.1111/sdi.13184. Epub 2023 Oct 24.

Abstract

Vascular access (VA) for hemodialysis (HD) continues to be the keystone of the technique's success. The first option should be an arteriovenous fistula (AVF) or arteriovenous graft (AVG), although in some scenarios the only possibility available is a central venous catheter, which could lead to an increase in vascular complications such as thoracic central vein occlusion (TCVO), becoming a challenge for physicians. If conventional therapies cannot be performed, a new device called the Surfacer® Inside-Out® Access Catheter System (IOA) (Bluegrass Vascular Technologies, San Antonio, TX, USA) arises as a promising alternative. Here we describe the case of a patient in which we performed a combination of two techniques: sharp recanalization plus Surfacer® Inside-Out® Access Catheter System.

Publication types

  • Case Reports

MeSH terms

  • Arteriovenous Fistula*
  • Arteriovenous Shunt, Surgical* / adverse effects
  • Catheterization, Central Venous* / adverse effects
  • Central Venous Catheters*
  • Humans
  • Renal Dialysis
  • Retrospective Studies
  • Treatment Outcome